Seres Therapeutics: 2Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Seres Therapeutics Inc. (MCRB) on Thursday reported a loss of $27.8 million in its second quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 68 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.
The drug developer posted revenue of $4.6 million in the period.
Seres Therapeutics shares have declined 24 percent since the beginning of the year. The stock has declined 43 percent in the last 12 months.